PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.54), $0.10 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $41.49 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.